{{Rsnum
|rsid=7964748
|Chromosome=12
|position=102571551
|Orientation=plus
|GMAF=0.2176
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 69.0 | 25.7 | 5.3
| HCB | 67.6 | 30.9 | 1.5
| JPT | 61.9 | 35.4 | 2.7
| YRI | 49.3 | 36.1 | 14.6
| ASW | 50.9 | 36.8 | 12.3
| CHB | 67.6 | 30.9 | 1.5
| CHD | 73.4 | 23.9 | 2.8
| GIH | 51.5 | 40.6 | 7.9
| LWK | 50.9 | 39.1 | 10.0
| MEX | 62.1 | 36.2 | 1.7
| MKK | 57.7 | 37.2 | 5.1
| TSI | 63.7 | 34.3 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=G
  |Pval=3E-6
  |OR=4.06
  |ORtxt=[2.37-5.75] mg/dL increase
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}